[1]于金玲翻译,朱江帆审校.腔内聚乙烯十二指肠-空肠导管对体重调节的作用：猪动物模型可行性研究[J].中国微创外科杂志,2007,07(1):12-14.
　Luca Milone,MD,Michel Gagner,et al.Effect of a polyethylene endoluminal duodenojejunal tube (EDJT) on weight gain: a feasibility study in a porcine model[J].Chinese Journal of Minimally Invasive Surgery,2007,07(1):12-14.
点击复制

腔内聚乙烯十二指肠-空肠导管对体重调节的作用：猪动物模型可行性研究()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
07
期数:
2007年1期
页码:
12-14
栏目:
国外微创外科动态
出版日期:
2007-01-20

文章信息/Info

Title:
Effect of a polyethylene endoluminal duodenojejunal tube (EDJT) on weight gain: a feasibility study in a porcine model
作者:
于金玲翻译; 朱江帆审校
上海同济大学医学院附属东方医院普外科，上海200120
Author(s):
Luca Milone; MD；Michel Gagner; MD; FACS; FRCSC；Kazuki Ueda; MD；Sergio J. Bardaro; MD；Yoon KiYoung; MD
New York Presbyterian Hospital, Weill College of Medicine of Cornell University, Department of Surgery, New York, NY, USA
关键词:
肥胖症手术; 腹腔镜; 腔内手术; 十二指肠手术; 体重
分类号:
R-332
文献标志码:
A
摘要:
目的评估十二指肠-空肠导管（Endoluminal DuodenoJejunal Tube，EDJT）在活体猪实验动物模型中减缓体重增加的可行性，及其在中短期生存中的安全性。方法本项研究共用8只45 kg重的Yorkshire猪，其中3只置入180 cm EDJT，1只置入360 cm EDJT，另4只猪作为对照组。切开十二指肠，将EDJT导管缝合固定在十二指肠近Vater壶腹起始处。结果评估全部猪的不适反应和体重，每日一次，共7周，未发现严重并发症发生。术后7周3组动物的平均体重变化百分率：对照组、180 cm组和360 cm组分别是22.5%，6%和-2.8%。EDJT组（180 cm组、360 cm组）体重增加明显减慢，与对照组相比，有统计学意义（P=0.05）。 结论EDJT可以安全使用，无肠梗阻、肠套叠或胰腺炎等并发症发生。EDJT可明显减缓体重增加。

参考文献/References:


[1]Flegal KM，Carroll MD，Ogden CL，et al. Prevalence and trends in obesity among US adults, 1999-2000.JAMA,2002,288:1723-1727.
[2]Buchwald H.A bariatric surgery algorithm.Obes Surg,2002,12:733-746,discussion 747-750.
[3]Payne J,DeWind L.Surgical treatment of obesity.Am J Surg,1969,118: 141-147.
[4]Inabnet W,Gagner M,Pomp A.Laparoscopic RouxenY gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths.Obes Surg,2005,15:51-57.
[5]Brolin R,Kenler HA,Gorman JH,et al.Longlimb gastric bypass in superobese. A prospective randomized study.Ann Surg,1992,215:387-395.
[6]Bruder S,Freeman J,BrazeauGravel P.Lengthening the RouxY limb increases weight loss after gastric bypass:a preliminary report.Obes Surg,1991,1:73-77.
[7]Kim WW,Gagner M,Pomp A,et al.Laparoscopic vs open biliopancreatic diversion with duodenal switch:a comparative study.J Gastrointest Surg,2003,7:552-557.
[8]Scopinaro N,Adami GF,Marinari G,et al.Biliopancreatic diversion:two decades of experience.In:Deitel M,Cowan GSM Jr,eds.Update:Surgery for the Morbidly Obese Patient.Toronto:FDCommunications Inc,2000.227-258.
[9Marceau P,Hould FS,Biron S,et al.Biliopancreatic diversion with duodenal switch.World J Surg,1998,22:947-954.
10Keshishian A,Zahriya K,Hartoonian T,et al.Duodenal switch is a safe operation for patients who have failed other bariatric operations.Obes Surg,2004,14:1187-1192.
11Rubino F,Forgione A,Marescaux J,et al.The role of the small bowel in the regulation of the circulating gherlin levels and food intake in the obese Zucker rat.Endocrinology,2005,146:1745-1751.
12Grandt D,Struk K,Reeve JR Jr.Two molecular forms of peptide YY (PYY) are abundant in human blood:characterization of a radioimmunoassay recognizing PYY 136 and PYY 336.Regul Pept,1994,51:151-159.
13Batterham RL,Cohen MA,Dakin CL,et al.Gut hormone PYY 336 physiologically inhibits food intake.Nature,2002,418:650-654. 全文刊登于Obesity Surgery,2006,16:1-7.

更新日期/Last Update: 2013-11-15